// App-Quantinova.ai

1995 : HuR dependent inhibition of PARG enhances PARP inhibitor therapy for DNA repair proficient and deficient pancreatic cancer cells

Researchers

Presenter

  • Saswati N. Chand

Principal Investigators

  • Mahsa Zarei

  • Akshay R. Kamath

  • Matthew J. Schiewer

  • Carmella Romeo

  • Joseph A. Cozzitorto

  • Nicole Meisner-Kober

  • Eric Londin

  • Isidore Rigoutsos

  • Karen Knudsen

  • John M. Pascal

  • Charles J. Yeo

  • Jordan M. Winter

  • Jonathan R. Brody

Medical Centers

  • Thomas Jefferson University, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Solid malignancies

Biomarkers

  • Hu antigen R

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved